Target intelligence / Profile preview

Neuron navigator 3 (NAV3)

Target
NAV3
Molecular classification
Cytoskeletal-associated protein, Microtubule plus-end tracking protein (+TIP), AAA+ ATPase domain-containing protein, Other (Navigator family protein)
01

Overview

Neuron navigator 3 (NAV3) is a large multidomain protein, highly conserved across species, and part of the navigator family. It binds microtubules at their growing tips (+TIP), facilitating polarized growth of microtubules and directional cell migration. NAV3 enhances cell adhesion to migration paths and suppresses random migration, thereby inhibiting cancer cell metastasis and promoting normal tissue development. In neurons, NAV3 is critical for axon formation, neuronal migration, and cytoskeletal reorganization. Pathogenic variants impair microtubule stabilization, resulting in intellectual disability and developmental defects. NAV3 is also implicated in immune cell regulation and organ morphogenesis, including the liver and heart.

Other names
KIAA0938POMFIL1Steerin-3unc53H3Pore membrane and/or filament-interacting-like protein 1Unc-53 homolog 3NEDSFB
02

Mechanism of action

For potential drugs: Restoration or stabilization of NAV3 function may stabilize microtubules, inhibit random migration and invasion, suppress metastasis, and regulate apoptosis in cancer cells. Experimental: Knockdown or mutation impairs microtubule stabilization and disrupts normal migration, invasion, and morphogenesis.

03

Biological functions

Cell migration (including cancer cell migration and invasion)Neurite growth and axon guidanceNeuron regenerationCytoskeletal organization (via microtubules and actin)Regulation of apoptosisPossibly regulation of IL2 production by T-cellsOrgan morphogenesis (liver and cardiac development, shown in model organisms)
04

Disease associations

Cancer (breast, lung; NAV3 is a putative tumor suppressor, its loss facilitates metastasis)Neurodevelopmental disorders (intellectual disability, microcephaly, neuronal migration deficit)Skeletal and ocular anomalies (by pathogenic NAV3 variants)Other tissue morphogenesis defects (e.g., liver, heart)
05

Safety considerations

As NAV3 regulates cytoskeletal structure essential for many cells, targeting NAV3 could theoretically risk off-target effects on neural development, immune regulation, and organogenesisLoss-of-function mutations produce significant developmental and organ morphology defects
06

Interacting drugs

None currently known or approved for direct NAV3 targeting
07

Biomarkers

Low NAV3 expression is associated with poor prognosis in breast and lung cancer and may serve as a biomarker for metastatic propensity.

Beyond the preview

Go deeper on Neuron navigator 3 (NAV3).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Neuron navigator 3 (NAV3).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call